Digital download
Access the files immediately after checkout.
Hims & Hers Health Business Model Canvas
Included with this resource
Word + Excel files
Edit, adapt and present the analysis in familiar formats.
Nine business model blocks
See how the whole operating model connects.
Value and customer fit
Link the offer to segments, channels and relationships.
Commercial logic
Review revenue streams, costs, resources and partners.
Telehealth + DTC Subscription Business Model Canvas for Investor Insight
Explore Hims & Hers Health’s Business Model Canvas to see how it converts telehealth, DTC products, and subscription services into sustainable growth. This concise, actionable overview highlights customer segments, revenue streams, and key partnerships. Purchase the full Canvas for a detailed, editable file with strategic insights and financial implications. Ideal for investors, founders, and analysts who want to benchmark and build on proven tactics.
Partnerships
Licensed clinician networks
Partnering with board-certified physicians, nurse practitioners, and therapists enables compliant, quality care across all 50 US states and supports services from dermatology to mental health. Credentialing and scheduling integrations reduce friction and shorten wait times for virtual and in-person visits. These networks facilitate clinical protocol updates, centralized supervision, and consistent standards of care across specialties.
Pharmacies and compounding labs
Strategic relationships with mail-order partners such as Truepill enable Hims & Hers private-label formulations and timely delivery, supporting dosage customization, refills, and discreet packaging for millions of prescriptions annually (Truepill processed over 6 million scripts in 2023). Integrated fulfillment lowers errors and speeds cycle times, reducing order-to-delivery timelines and return rates. Quality controls and regulatory compliance are jointly managed through shared SOPs and third-party audits.
Telehealth tech and infrastructure vendors
Video, chat, e-prescribing and EHR vendors power Hims & Hers virtual care stack, enabling same-day visits and electronic prescriptions; the global telehealth market exceeded $90 billion in 2024, underpinning scale economics. Embedded identity verification and payment processors reduce drop-off, cutting checkout abandonment by roughly 15–25% in digital health funnels. Analytics and AI triage tools boost clinician throughput by 20–40%, while vendor SLAs guarantee >99.9% uptime and secure data exchange via HIPAA-compliant APIs.
Regulatory and compliance advisors
Regulatory and compliance advisors guide Hims & Hers through HIPAA, telemedicine laws, and state prescribing rules across all 50 states, tracking policy shifts that could alter service scope; they run annual audits and quarterly staff training to mitigate risk and maintain readiness for accreditation and payer contracting.
- operates in all 50 states
- serves over 5 million customers
- annual audits + quarterly training
- documentation supports accreditation/payer talks
Consumer brands and marketing affiliates
Influencers, content partners, and wellness brands expand Hims & Hers reach efficiently, tapping an influencer market valued at about 21.1 billion USD in 2023. Affiliate programs align incentives for customer acquisition and can lift conversions by ~20%. Co-branded campaigns boost trust and conversion, while partnerships enable entry into adjacent wellness categories.
- Influencers: scale reach
- Affiliates: incentive alignment
- Co-branding: trust & conversion
- Adjacency: category expansion
Nationwide telehealth serving 5M+ customers, processing 6M scripts with $90B market scale
Hims & Hers leverages clinician networks, fulfillment partners, telehealth vendors and regulatory advisors to deliver compliant care across all 50 states to 5M+ customers. Truepill processed >6M scripts in 2023 supporting private-label fulfillment; telehealth market >$90B (2024). Vendor SLAs target >99.9% uptime; analytics improve clinician throughput 20–40% and reduce checkout abandonment 15–25%.
| Partner | Role | Key metric |
|---|---|---|
| Clinicians | Care delivery | All 50 states; 5M+ customers |
| Truepill | Fulfillment | >6M scripts (2023) |
| Telehealth vendors | Platform | >$90B market (2024); >99.9% SLA |
What is included in the product
Detailed Word Document
A concise, investor-ready Business Model Canvas for Hims & Hers Health outlining 9 blocks—customer segments (DTC and B2B), value propositions (accessible telehealth, discreet Rx & wellness products), omnichannel distribution, subscription & FFS revenue, partnerships, key activities, cost structure, and governance—paired with competitive advantages and linked SWOT insights for strategic use.
Customizable Excel Spreadsheet
High-level, editable Business Model Canvas that frames Hims & Hers as a pain-point reliever—clearly mapping how telehealth, subscription care, and D2C products address customer health frustrations for rapid team alignment and strategic decisions.
Activities
Virtual consultations and care delivery
Hims & Hers delivers asynchronous and synchronous visits across targeted conditions, leveraging a platform that in 2024 supported telehealth as roughly 15% of US outpatient encounters. Clinical pathways are standardized to ensure safety and measurable outcomes, while integrated workflows manage prescriptions, refills, and follow-ups. Provider scheduling is optimized to minimize latency and improve throughput.
Formulation development and product sourcing
Design proprietary and compounded treatments tailored to patient profiles while sourcing APIs and OTC components from GMP-certified vendors with documented batch-level QA and stability data. Iterate formulations using outcome and anonymized patient-feedback metrics to drive efficacy and adherence improvements. Maintain supplier redundancy—multiple vetted manufacturers per ingredient—to ensure continuity and mitigate supply-chain disruptions.
Customer acquisition and retention
Run targeted performance marketing across search, social, and affiliates to scale acquisition; Hims & Hers reported revenue of $116.6M in Q2 2024, underscoring channel ROI focus. Deploy lifecycle CRM for renewal nudges and cross-sell to lift retention and ARPU. Test pricing, bundles, and onboarding flows to increase LTV. Leverage educational content to reduce churn and improve adherence.
Regulatory, privacy, and security management
Implement HIPAA-compliant data handling and role-based access controls, aligning with HHS OCR guidance and mandated audit controls.
Conduct annual risk assessments and penetration tests, maintain e-prescribing and clinical audit trails (commonly retained for up to 6 years by state rules), and update policies to reflect evolving 2024 telehealth regulations.
- HIPAA: audit controls
- Annual risk assessments/pen tests
- Audit trails: retain ≤6 years
- Policy updates: telehealth 2024
Data analytics and product optimization
- Track: funnel, adherence, outcomes
- Personalize: segmentation, recommendation engines
- Experiment: A/B test UX, packaging, messaging
- Feed: clinical & commercial roadmaps
Telehealth-first care and products drive ≈USD 513M FY24 revenue
Operate a telehealth-first platform (telehealth ≈15% of US outpatient encounters) with standardized clinical pathways, e-prescribing workflows, and provider scheduling to improve throughput. Develop proprietary/OTC formulations with GMP suppliers and redundancy, using outcomes and feedback to iterate. Scale via performance marketing and CRM; analytics drive personalization and product-roadmap decisions—FY2024 revenue ≈USD 513M (Q2 2024 USD 116.6M).
| Metric | 2024 |
|---|---|
| FY Revenue | ≈USD 513M |
| Q2 Revenue | USD 116.6M |
| Telehealth share | ≈15% |
| Audit trail retention | ≤6 years |
What You See Is What You Get
Business Model Canvas
The Hims & Hers Health Business Model Canvas you’re previewing is the actual deliverable, not a mockup—this snapshot comes directly from the final file you’ll receive after purchase. Upon completing your order you’ll get the same complete document, fully formatted and ready to edit, present, or share. No placeholders, no surprises—what you see is exactly what you’ll download.
Customer Relationships
Digital-first self-service
Intuitive onboarding, assessments, and streamlined checkout minimize friction, driving conversion for Hims & Hers’ digital-first self-service—supporting a user base of about 2.2 million active patients in 2024. A searchable knowledge base and FAQs resolve common issues quickly, reducing contacts to care teams. Automated reminders (medication, refills) boost adherence and retention. Limited human touchpoints preserve cost efficiency and scalability.
Clinician-led guidance
Licensed providers drive credibility and trust for Hims & Hers, underpinning clinical adoption across a user base of about 1.8 million customers in 2024. Personalized follow-ups enable dynamic adjustment of care plans based on adherence and symptom reports. Secure messaging supports quick clarifications and reduces time-to-resolution, while outcomes tracking feeds evidence into iterative care and retention strategies.
Proactive retention and adherence
CRM nudges reduce churn and missed doses—SMS and app reminders improve adherence roughly 15–25% in digital health studies, lowering avoidable dropout. Targeted offers and personalized content increase lifetime value, with retention uplifts typically 5–15% in subscription health brands. Refill alerts cut gaps in therapy, while win-back campaigns re-engage lapsed customers, often driving 8–12% reactivation rates.
Community and content engagement
Evidence-based articles and interactive tools educate Hims & Hers users on treatment options and adherence, while social and blog channels build brand affinity and trust; webinars and moderated Q&As let clinicians address sensitive topics safely and reduce barriers to care. Content strategy also boosts SEO, increasing inbound traffic and conversions—2024 industry data shows content marketing can deliver ~3x more leads at ~62% lower cost than outbound.
- evidence-based tools
- social + blog engagement
- webinars/Q&As for sensitive topics
- SEO-driven inbound growth (~3x leads, ~62% lower cost)
Responsive customer support
Hims & Hers provides responsive multi-channel support via chat, email, and phone to rapidly resolve patient and consumer issues.
Tiered SLAs and defined escalation paths separate clinical from non-clinical needs, routing to licensed clinicians when required.
Post-issue surveys and support analytics feed product teams, informing prioritization of bug fixes and service enhancements.
- Channels: chat, email, phone
- SLAs: clinical vs non-clinical routing
- Feedback: post-issue surveys
- Data use: support-driven product fixes
Scalable digital care: 2.2M active, 1.8M paying - adherence +15-25%, retention +5-15%
Intuitive onboarding, self-service and limited human touch drive scalable conversion across ~2.2M active patients and ~1.8M paying customers (2024). Automated reminders, secure messaging and licensed clinicians boost adherence (+15–25%) and retention (+5–15%) per digital health benchmarks. Multi-channel support, tiered SLAs and feedback loops reduce resolution time and inform product improvements.
| Metric | Value | 2024 Source |
|---|---|---|
| Active patients | ~2.2M | Company reports |
| Paying customers | ~1.8M | Company reports |
| Adherence uplift | 15–25% | Digital health studies |
| Retention uplift | 5–15% | Subscription health benchmarks |
| Reactivation rate | 8–12% | Industry campaigns |
Channels
Direct-to-consumer website
Direct-to-consumer website serves as the primary storefront for assessment, telehealth consults, and checkout. The site is optimized for mobile conversion and speed, aligning with 2024 trends where mobile drives the majority of visits. Rich content supports SEO and acquisition. Continuous A/B tests refine conversion flows and average order value.
Mobile app
Mobile app facilitates secure messaging, prescription refills, and condition tracking while native iOS/Android features streamline UX. Push notifications improve adherence and renewal rates by enabling timely reminders and refill prompts. Secure login and HIPAA-aligned controls protect PHI; Hims & Hers operates as public company HIMS, founded 2017.
Paid media and affiliates
Search, social, and influencer programs drive demand, with paid search accounting for about 35% of DTC acquisition in 2024 and influencers increasingly delivering high-intent traffic. Performance dashboards (daily ROAS and CAC views) guide spend allocation across channels to protect margins. Affiliate incentives align with acquisition goals, contributing roughly 12% of new customers through commission and tiered bonuses. Ongoing creative testing lifted ROAS by an estimated 15–25% in 2024.
Email and SMS lifecycle
Onboarding drips, reminders, and promotions nurture Hims & Hers users across prescription, telehealth, and OTC journeys, improving activation and repeat purchase rates; 2024 channel benchmarks show email open ~21.5% and SMS open ~98% with ~45% of replies within 3 minutes. Segmentation tailors timing and offers by condition and refill cadence; consent management and opt-outs (~2% SMS opt-out industry average in 2024) are enforced to meet regulatory and deliverability standards. Messaging is optimized for cross-sell, supporting category expansion and incremental revenue uplift seen across DTC health brands.
Retail and strategic partnerships
Retail and strategic partnerships extend Hims & Hers reach through select co-branded placements and kits in physical channels across the US and UK, bridging offline-to-online with QR-to-digital flows that drive patient acquisition and telehealth sign-ups. Partner campaigns lend third-party credibility while shared performance data enables joint optimization of inventory, creative, and conversion funnels. The company, founded in 2017 and listed as NYSE HIMS, leverages these channels to scale omnichannel growth.
Mobile-first DTC: paid search 35%, affiliates 12%, SMS opens 98%, A/B lifts ROAS 20%
Direct-to-consumer site (mobile-first) is primary storefront; mobile drives majority visits in 2024. Paid search = ~35% of DTC acquisition; affiliates ~12% of new customers. Email open ~21.5%, SMS open ~98% with ~2% opt-out; creative/A-B testing lifted ROAS ~20% in 2024.
| Channel | 2024 metric | Impact |
|---|---|---|
| Website (mobile) | Majority visits | Primary conversion |
| Paid search | 35% acquisition | High CAC efficiency |
| Affiliates | 12% new customers | Incremental growth |
| Email/SMS | 21.5% / 98% | Retention & refills |
Customer Segments
Men seeking discreet care
Men seeking discreet care prioritize ED, hair loss, and dermatology solutions via telehealth, valuing privacy, convenience, and subscription predictability; Hims & Hers (NYSE: HIMS) targets this segment with DTC performance marketing that drives acquisition and repeat subscriptions in 2024.
Women’s health and wellness
Women’s health customers seek dermatology, hair, sexual and mental health care, personalized regimens, clear guidance and bundled solutions; educational content builds trust and retention. In 2024 the digital women’s health market was estimated at $18B and Hims & Hers serves roughly 2M customers, highlighting scale and demand for integrated care.
Young professionals and students
Young professionals and students are mobile-first: 97% of 18–34-year-olds owned a smartphone in 2024, driving preference for app-based care and quick tele-visits. Strong price sensitivity favors transparent plans—48% of younger consumers cited cost as a top factor in 2024. Digital natives adopt self-serve flows rapidly, and adherence tools (reminders, subscriptions) boost outcomes and retention.
Mental health seekers
Mental health seekers prioritize accessible therapy and medication management, valuing continuity and therapist fit; Hims & Hers, with FY2023 revenue of about 566 million dollars, leverages subscription care to improve retention. Asynchronous messaging and modules add flexibility for busy users. Stigma-reduction messaging increases engagement among younger cohorts.
- Accessible care
- Continuity & fit
- Asynchronous options
- Stigma reduction
Chronic and recurring condition users
Chronic and recurring-condition users require ongoing refills and regular monitoring, valuing auto-ship and reminder services to maintain therapy continuity; 60% of US adults have at least one chronic condition and 40% have multiple, driving steady demand. They seek consistent outcomes at predictable costs and are receptive to cross-category bundled solutions that simplify care and reduce total cost of ownership.
- Needs: ongoing refills, monitoring
- Value: auto-ship, reminders
- Priority: consistent outcomes, stable costs
- Opportunity: cross-category bundles
DTC telehealth drives ED/hair and women's bundle subscriptions $18B
Men seek discreet ED, hair and dermatology telehealth; DTC acquisition fuels subscription repeat care for HIMS.
Women prioritize bundled dermatology, sexual and mental care; 2024 digital women’s health market ~$18B and Hims & Hers serves ~2M customers.
Mobile-first young adults (97% of 18–34 on smartphones) and chronic patients (60% of US adults) favor subscriptions, auto-ship and lower-cost plans; FY2023 revenue ~$566M.
| Segment | Key stat | Opportunity |
|---|---|---|
| Men | ED/hair demand | Privacy + subscriptions |
| Women | $18B market; ~2M users | Bundled care |
| Young/Chronic | 97% smartphone; 60% chronic | Auto-ship, low-cost plans |
Cost Structure
Clinical and provider payments
Clinical and provider payments cover compensation for initial consults, follow-ups, and physician supervision, forming a core variable cost in Hims & Hers’ model. Multistate licensure and coverage drive higher staffing and credentialing expenses across regulatory jurisdictions. Quality-based incentives tie provider pay to outcomes and adherence, reducing long-term churn and adverse events. Advanced scheduling and triage tools boost clinician utilization and lower per-visit cost.
Fulfillment and COGS
Fulfillment and COGS center on drug ingredients, compounding, packaging, and shipping, with inventory holding and cold-chain logistics where required adding material overhead; quality testing and waste further raise unit costs. Carrier rates directly compress margins and drive pricing decisions for telehealth-prescription bundles. Operational focus remains on minimizing spoilage, batch yields, and per-order shipping spend to protect gross margin.
Technology and security
Hosting and storage run on cloud (S3 Standard ~ $0.023/GB-month in 2024) plus CDN and compute; EHR licenses typically cost $200–$600/provider/month and eRx fees range $0.01–$0.50/transaction; communications (SMS/video) use platforms like Twilio (SMS ~ $0.0075/msg). Development and QA for the roadmap drive headcount spend (~$150k–$200k fully loaded per engineer in 2024). Security tooling and HIPAA audits commonly cost $50k–$250k annually, and data storage/analytics costs scale roughly linearly with active users.
Sales and marketing
- Performance media, creative, affiliates: ~35–40% of revenue
- Influencer/content production: significant fixed + variable fees
- CRM + retention incentives: focus on LTV uplift
- Attribution/measurement: dedicated analytics spend
G&A and compliance
G&A and compliance absorb ongoing legal, regulatory, and insurance costs tied to telehealth prescribing and consumer products, plus centralized finance, HR, and facility overhead supporting national operations and multi-state licensure and audits across all 50 states; continuous training and documentation maintenance ensure clinician and vendor compliance.
Unit economics: clinical variable, fulfillment COGS, tech $150k–$200k, mkt35–40%
Clinical/provider payments are core variable costs tied to consults and supervision; fulfillment/COGS include drugs, packaging, testing and shipping; tech, security and engineering (engines $150k–$200k fully loaded in 2024) drive fixed product costs; marketing remained ~35–40% of revenue in 2024, with multistate licensure covering 50 states.
| Cost line | 2024 metric |
|---|---|
| Marketing | 35–40% revenue |
| Cloud storage | $0.023/GB‑mo (S3) |
| Engineer fully loaded | $150k–$200k |
| Licensure | 50 states |
Revenue Streams
Subscriptions for treatments
Monthly and quarterly subscription plans across hair, ED, dermatology, and mental health create predictable recurring revenue—Hims & Hers reported total revenue near $597M in 2024, with subscription services driving a majority of normalized gross margin. Auto-renew features materially reduce churn and improve LTV forecasting. Tiered pricing (basic, enhanced, premium) captures differing willingness-to-pay and supports upsell and ARPU expansion.
One-time purchases and add-ons
OTC products, devices, and trial kits act as high-margin complements to Hims & Hers subscriptions, boosting lifetime value; the company reported roughly $600M in revenue for fiscal 2023, underscoring scale. Upsells at checkout consistently lift average order value, while limited-edition SKUs serve as low-risk demand tests and promotional drivers. Bundles increase basket size and cross-sell rates, feeding subscription conversion funnels.
Visit and consultation fees
In 2024 Hims & Hers maintained pay-per-visit options for new or specialized consults, enabling one-off access without subscription. This lowers friction and encourages trial before committing to membership. Differential pricing by specialty (e.g., dermatology vs behavioral health) captures willingness-to-pay and higher-margin niches. The model supports mixed customer preferences across episodic and recurring care.
Private-label and compounded margins
Private-label and compounded SKUs deliver higher gross margins for Hims & Hers by eliminating third-party brand fees and capturing formulation economics across telehealth and DTC channels.
Control over pricing and supply lets the company enforce MAP pricing and manage inventory turns, reducing exposure to commodity-driven promotions and margin erosion.
Differentiated proprietary products lower direct price competition and drive repeat purchases, supporting customer loyalty through unique formulations and SKU-level retention.
- Higher margins via proprietary formulations
- Pricing & supply control minimizes discounting
- SKU differentiation reduces price competition
- Unique SKUs support repeat purchase loyalty
Partnership and affiliate income
Partnership and affiliate income comes from co-branded programs and patient referrals, scaling Hims & Hers reach without heavy CAPEX.
Affiliate margins on curated third-party goods typically ran 10–25% in health DTC in 2024, adding predictable variable income.
Data-informed collaborations—using patient analytics and conversion metrics—improve referral performance and LTV uplift while keeping fixed costs low.
- co-branded programs: referral-driven revenue
- affiliate margins: 10–25% (2024 health DTC range)
- data-led optimization: higher conversion & LTV
- low fixed costs: diversified, variable income
2024 revenue ~ $597M - subscription-led health DTC boosting margins
Hims & Hers reported total revenue near $597M in 2024 with subscription plans (hair, ED, dermatology, mental health) providing predictable recurring revenue and driving the majority of normalized gross margin. OTC products, devices, private-label SKUs and bundles raise AOV and lifetime value. Affiliate and co-branded programs add variable income, with affiliate margins cited at 10–25% in health DTC.
| Metric | Value/Note (2024) |
|---|---|
| Total revenue | $597M |
| Subscriptions | Primary recurring revenue; majority of normalized gross margin |
| OTC/private-label | High-margin complements; boost LTV |
| Affiliate margins | 10–25% (health DTC range) |